News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,539 Results
Type
Article (39642)
Company Profile (268)
Press Release (642629)
Section
Business (204114)
Career Advice (2007)
Deals (35400)
Drug Delivery (80)
Drug Development (80864)
Employer Resources (168)
FDA (16075)
Job Trends (14858)
News (344726)
Policy (32477)
Tag
Academia (2561)
Africa (721)
Alliances (49156)
Alzheimer's disease (1172)
Approvals (16001)
Arizona (180)
Artificial intelligence (87)
Asia (37025)
Australia (6044)
Bankruptcy (352)
Best Places to Work (11403)
Biosimilars (65)
Biotechnology (191)
Breast cancer (74)
C2C Services and Suppliers (78915)
California (2129)
Canada (1014)
Cancer (621)
Career advice (1672)
Cell therapy (151)
China (166)
Clinical research (63560)
Collaboration (194)
Colorado (87)
Compensation (112)
Connecticut (89)
COVID-19 (2508)
Cystic fibrosis (78)
Data (473)
Diabetes (98)
Diagnostics (6012)
Drug pricing (72)
Earnings (83762)
Employer resources (143)
Europe (79351)
Events (108402)
Executive appointments (184)
FDA (16381)
Florida (310)
Funding (188)
Gene therapy (105)
Georgia (69)
GLP-1 (531)
Government (4324)
Healthcare (18663)
Hotbed/Location (481752)
Illinois (278)
Indiana (156)
Infectious disease (2549)
Inflammatory bowel disease (93)
Interviews (315)
IPO (16236)
Job creations (3642)
Job search strategy (1431)
Kansas (94)
Layoffs (402)
Legal (7850)
Lung cancer (122)
Manufacturing (113)
Maryland (440)
Massachusetts (1749)
Medical device (13097)
Medtech (13102)
Mergers & acquisitions (19082)
Metabolic disorders (286)
Michigan (132)
Minnesota (227)
Neuroscience (1358)
New Jersey (653)
New York (669)
NextGen Class of 2024 (6516)
Non-profit (4476)
North Carolina (613)
Northern California (924)
Obesity (173)
Ohio (115)
Opinion (173)
Patents (80)
Pennsylvania (632)
People (56113)
Phase I (19690)
Phase II (27984)
Phase III (20911)
Pipeline (140)
Postmarket research (2554)
Preclinical (8378)
Radiopharmaceuticals (230)
Rare diseases (152)
Real estate (5913)
Regulatory (21325)
Research institute (2330)
Resumes & cover letters (349)
South America (1094)
Southern California (860)
Startups (3586)
Texas (276)
United States (9513)
Vaccines (493)
Washington State (267)
Weight loss (139)
Date
Today (90)
Last 7 days (675)
Last 30 days (2747)
Last 365 days (36727)
2024 (27565)
2023 (40178)
2022 (51265)
2021 (55820)
2020 (54191)
2019 (46647)
2018 (35130)
2017 (32201)
2016 (31620)
2015 (37692)
2014 (31466)
2013 (26495)
2012 (28684)
2011 (29384)
2010 (27420)
682,539 Results for "gate neurosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gate Neurosciences to Share New Data and Research Insights on its Synaptic Function Molecules with Multiple Posters at 2024 ASCP Annual Meeting
Gate Neurosciences today announced upcoming activities at the 2024 annual meeting of the American Society of Clinical Psychopharmacology (ASCP), being held in Miami Beach, FL, from May 28-31, 2024.
May 15, 2024
·
4 min read
Business
Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
Gate Neurosciences today announced a strategic collaboration with Beacon Biosignals to further advance the use of electroencephalogram (EEG) biomarkers across the company’s clinical pipeline in neuropsychiatry and cognition.
January 24, 2024
·
4 min read
BioMidwest
Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announced the publication of its manuscript titled, " rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels,[1]” in the peer-reviewed journal, Frontiers in Molecular Neuroscience.
May 16, 2024
·
6 min read
Drug Development
Gate Neurosciences Announces Positive Topline Human EEG Biomarker Results Demonstrating Dose-Dependent Target Activation in Phase 1 Study of Apimostinel
Gate Neurosciences, a clinical-stage biotechnology company using precision medicine approaches to develop next-generation neuroscience therapies, today announced positive topline qEEG biomarker and safety results from its Phase 1 multiple ascending dose study of apimostinel in healthy volunteers.
November 7, 2023
·
4 min read
Business
Dr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer, starting June 10, 2024.
May 28, 2024
·
3 min read
BioMidwest
Gate Neurosciences Hones in on Precision Medicine with Expanded Research Operations Supporting Its Synaptic Function-Enhancing Molecules
Gate Neurosciences announced it has increased its R&D capabilities with new expanded research operations and lab facilities in Evanston, Illinois.
May 3, 2023
·
4 min read
Press Releases
Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)
September 30, 2024
·
5 min read
Biotech Bay
Gate Bioscience Emerges from Stealth and Introduces Molecular Gates, a New Class of Small Molecule Therapeutics
Gate Bioscience, a biotechnology company creating a new class of medicines called Molecular Gates, unveiled the company and its scientific platform.
November 1, 2023
·
7 min read
Deals
Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.
Numinus Wellness Inc. announces today that it has entered into an agreement to divest its holdings in Alto Neuroscience Inc. (“Alto”), a clinical-stage biopharmaceutical company.
February 1, 2024
·
3 min read
Press Releases
Immorna Receives Grant from Bill & Melinda Gates Foundation to Support Its mRNA RSV Vaccine Clinical Development
August 26, 2024
·
4 min read
1 of 68,254
Next
